Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2002 2
2003 2
2004 3
2005 6
2006 8
2007 12
2008 4
2009 8
2010 6
2011 5
2012 2
2013 3
2014 4
2015 6
2016 3
2017 3
2018 5
2019 14
2020 29
2021 29
2022 25
2023 31
2024 31
2025 71

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

278 results

Results by year

Filters applied: . Clear all
Page 1
Peripheral T-Cell Lymphoma: What's Next?
Yoon SE, Kim WS. Yoon SE, et al. Hematol Oncol. 2025 Jun;43 Suppl 2(Suppl 2):e70069. doi: 10.1002/hon.70069. Hematol Oncol. 2025. PMID: 40517441 Free PMC article. Review.
Conditions to Consider When Choosing Fillers.
Hong GW, Wan J, Yoon SE, Wong S, Yi KH. Hong GW, et al. Among authors: yoon se. J Cosmet Dermatol. 2025 Mar;24(3):e70075. doi: 10.1111/jocd.70075. J Cosmet Dermatol. 2025. PMID: 40062708 Free PMC article.
Exosomal miR-155-5p drives ibrutinib resistance in B-cell lymphoma.
Park B, Choi ME, Ryu KJ, Park C, Choi M, Yoon SE, Kim WS, Kim HH, Hong JY, Kim SJ. Park B, et al. Among authors: yoon se. Exp Cell Res. 2024 Oct 1;442(2):114248. doi: 10.1016/j.yexcr.2024.114248. Epub 2024 Sep 10. Exp Cell Res. 2024. PMID: 39260673
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium.
Han JX, Koh MJ, Boussi L, Sorial M, McCabe SM, Peng L, Singh S, Eche-Ugwu IJ, Gabler J, Fernandez Turizo MJ, MacVicar CT, Garg A, Disciullo A, Chopra K, Lenart A, Nwodo E, Barnes J, Koh MJ, Miranda E, Chiattone C, Stuver R, Horwitz SM, Merrill M, Jacobsen E, Manni M, Civallero M, Skrypets T, Lymboussaki A, Federico M, Kim Y, Kim JS, Cho JY, Eipe T, Shet T, Sridhar E, Shetty A, Saha S, Jain H, Sengar M, Van Der Weyden C, Prince HM, Hamouche R, Muradashvili T, Foss F, Gentilini M, Casadei B, Zinzani PL, Okatani T, Yoshida N, Yoon SE, Kim WS, Panchoo G, Mohamed Z, Verburgh E, Alturas JC, Al-Mansour M, Ford J, Cabrera ME, Ku A, Bhagat G, Ma H, Sawas A, Kariya KM, Iwasaki M, Bhanushali F, O'Connor OA, Marchi E, Shen C, Shah D, Jain S. Han JX, et al. Among authors: yoon se. Blood Adv. 2025 Feb 11;9(3):583-602. doi: 10.1182/bloodadvances.2024014674. Blood Adv. 2025. PMID: 39481087 Free PMC article.
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations.
Lin GW, Xu C, Chen K, Huang HQ, Chen J, Song B, Chan JKC, Li W, Liu W, Shih LY, Chuang WY, Kim WS, Tan W, Peng RJ, Laurensia Y, Cheah DMZ, Huang D, Cheng CL, Su YJ, Tan SY, Ng SB, Tang TPL, Han K, Wang VY, Jia WH, Pei Z, Li YJ, Gao S, Shi Y, Hu Z, Zhang F, Zhang B, Zeng YX, Shen H, He L, Ong CK, Lim ST, Chanock S, Kwong YL, Lin D, Rothman N, Khor CC, Lan Q, Bei JX; International NKTCL Working Group. Lin GW, et al. Lancet Oncol. 2020 Feb;21(2):306-316. doi: 10.1016/S1470-2045(19)30799-5. Epub 2019 Dec 23. Lancet Oncol. 2020. PMID: 31879220
278 results